Clinical Trial Update: Rapidity of Response to Adalimumab Treatment in Patients With Crohn´s Disease [Phase 4]

View source ↗

Summary

This update reports results from a Phase 4 study evaluating the speed of response to adalimumab in patients with moderate-to-severe Crohn's disease. The trial w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Humira (adalimumab)

Snippet

Sponsor: AbbVie | Conditions: Moderate to Severe Crohn's Disease | Phase 4 | Status: COMPLETED | Results posted: 2017-08-29